Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   The Metabolic Basis of Kidney Cancer
  2. Linehan, W. Marston; Schmidt,Laura; Crooks, Daniel R.; Wei, Darmood; Srinivasan, Ramaprasad; Lang, Martin; Ricketts, Christopher J.
  3. Cancer discovery. 2019, AUG; 9(8): 1006-1021.
  1. 2.   HECT and RING finger families of E3 ubiquitin ligases at a glance
  2. Metzger, M. B.; Hristova, V. A.; Weissman, A. M.
  3. Journal of Cell Science. 2012, Feb; 125(3): 531-537.
  1. 3.   Preferred drifting along the DNA major groove and cooperative anchoring of the p53 core domain: mechanisms and scenarios
  2. Pan, Y. P.; Nussinov, R.
  3. Journal of Molecular Recognition. 2010, Mar-Apr; 23(2): 232-240.
  1. 4.   The Mechanism of Ubiquitination in the Cullin-RING E3 Ligase Machinery: Conformational Control of Substrate Orientation
  2. Liu, J.; Nussinov, R.
  3. Plos Computational Biology. 2009 5(10):
  1. 5.   Targeting the ubiquitin-proteasome system for cancer therapy
  2. Yang, Y. L.; Kitagaki, J.; Wang, H.; Hou, D. X.; Perantoni, A. O.
  3. Cancer Science. 2009 100(1): 24-28.
  1. 6.   P53-induced DNA bending: The interplay between p53-ONA and p53-p53 interactions
  2. Pan, Y. P.; Nussinov, R.
  3. Journal of Physical Chemistry B. 2008 112(21): 6716-6724.
  1. 7.   Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis
  2. Tozluoglu, M.; Karaca, E.; Haliloglu, T.; Nussinov, R.
  3. Nucleic Acids Research. 2008 36(15): 5033-5049.
  1. 8.   Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13
  2. Ivanov, S. V.; Salnikow, K.; Ivanova, A. V.; Bai, L.; Lerman, M. I.
  3. Oncogene. 2007, Feb; 26(6): 802-812.
  1. 9.   Structural basis for p53 binding-induced DNA bending
  2. Pan, Y. P.; Nussinov, R.
  3. Journal of Biological Chemistry. 2007, Jan; 282(1): 691-699.
  1. 10.   Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
  2. Wei, M. H.; Toure, O.; Glenn, G. M.; Pithukpakorn, M.; Neckers, L.; Stolle, C.; Choyke, P.; Grubb, R.; Middelton, L.; Turner, M. L.; Walther, M. M.; Merino, M. J.; Zbar, B.; Linehan, W. M.; Toro, J. R.
  3. Journal of Medical Genetics. 2006, JAN; 43(1): 18-27.
  1. 11.   Multiple roles of Rbx1 in the VBC-Cul2 ubiquitin ligase complex
  2. Megumi, Y.; Miyauchi, Y.; Sakurai, H.; Nobeyama, H.; Lorick, K.; Nakamura, E.; Chiba, T.; Tanaka, K.; Weissman, A. M.; Kirisako, T.; Ogawa, O.; Iwai, K.
  3. Genes to Cells. 2005, JUL; 10(7): 679-691.
  1. 12.   The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins
  2. Ma, B. Y.; Pan, Y. P.; Gunasekaran, K.; Keskin, O.; Venkataraghavan, R. B.; Levine, A. J.; Nussinov, R.
  3. Physical Biology. 2005, JUN; 2(2): S56-S66.
  1. 13.   Regulating the p53 system through ubiquitination
  2. Yang, Y. L.; Li, C. C. H.; Weissman, A. M.
  3. Oncogene. 2004 23(11): 2096-2106.
  1. 14.   Expression of hypoxia-lnducible cell-surface transmembrane carbonic anhydrases in human cancer
  2. Ivanov, S.; Liao, S. Y.; Ivanova, A.; Danilkovitch-Miagkova, A.; Tarasova, N.; Weirich, G.; Merrill, M. J.; Proescholdt, M. A.; Oldfield, E. H.; Lee, J.; Zavada, J.; Waheed, A.; Sly, W.; Lerman, M. I.; Stanbridge, E. J.
  3. American Journal of Pathology. 2001 158(3): 905-919.
  1. 15.   Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells
  2. Mei, J. M.; Hord, N. G.; Winterstein, D. F.; Donald, S. P.; Phang, J. M.
  3. Faseb Journal. 2000 14(9): 1188-1201.
  1. 16.   Phosphorylation status and function of p53 are inversely related to protein kinase C activation
  2. Nakamura, K.; Sun, Y.; Yokoyama, Y.; Ferris, D.; Singh, N.; Ichikawa, T.; Shinozuka, K.; Kunitomo, M.; Colburn, N.
  3. Anticancer Research. 2000 20(1A): 1-5.
  1. 17.   Inactivation of p53 by human T-cell lymphotropic virus type 1 tax requires activation of the NF-kappa B pathway and is dependent on p53 phosphorylation
  2. Pise-Masison, C. A.; Mahieux, R.; Jiang, H.; Ashcroft, M.; Radonovich, M.; Duvall, J.; Guillerm, C.; Brady, J. N.
  3. Molecular and Cellular Biology. 2000 20(10): 3377-3386.
  1. 18.   Regulation and activation of p53 and its family members
  2. Lohrum, M. A. E.; Vousden, K. H.
  3. Cell Death and Differentiation. 1999 6(12): 1162-1168.
  1. 19.   Cancer as a complex developmental disorder - Nineteenth Cornelius P. Rhoads Memorial Award Lecture
  2. Dean, M.
  3. Cancer Research. 1998 58(24): 5633-5636.
  1. 20.   Regulation of Mdm2-Directed Degradation By the C Terminus of P53
  2. Kubbutat, M. H. G.; Ludwig, R. L.; Ashcroft, M.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1998 18(10): 5690-5698.
  1. 21.   Dispensability of P53 Degradation For Tumorigenicity and Decreased Serum Requirement of Human Papillomavirus Type 16e6
  2. Inoue, T.; Oka, K.; Yongil, H.; Vousden, K. H.; Kyo, S.; Jing, P.; Hakura, A.; Yutsudo, M.
  3. Molecular Carcinogenesis. 1998 21(3): 215-222.
  1. 22.   Vitamin E Succinate Inhibits Proliferation of Bt-20 Human Breast Cancer Cells - Increased Binding of Cyclin a Negatively Regulates E2f Transactivation Activity
  2. Turley, J. M.; Ruscetti, F. W.; Kim, S. J.; Fu, T.; Gou, F. V.; Birchenallroberts, M. C.
  3. Cancer Research. 1997 57(13): 2668-2675.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel